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1. Introduction
  Asthma is a common disease and its prevalence rising 
worldwide, with the highest prevalence in industrialized 
countries. Asthma affect about 300 million people worldwide 
and it has been estimated that a further 100 million will 
be affected by 2025[1,2]. Asthma is a complex inflammatory 
disease cause’s airway narrowing and associated with 
change in the levels of mast cells, lymphocytes, cytokines 
and other inflammatory cell products. Abrus precatorius Linn 
(Fabacease) (A. precatorius) is climbing shrubs; leaves are 
pinnate with many pairs of leaflets. Leaves 5-10 cm long, 
leaflets 10-20 pairs, opposite, flowers are pink clustered. 
The leaves and roots are sweetish and traditionally used to 
cure fever, stomatitis, asthma and bronchititis[3]. The roots, 
stems, and leaves also contain glycyrrhizin[4]. It possesses 
different pharmacological activities antimicrobial[5,6], 
antifertility[7], anti-implantationp[8], antibacterial activity[9], 
anti-tumor[10], immunopotentiating[11], sperm antimotility[12] 
and antidiarrhoeal[13]. Lectins derived from abrus shows 
immunostimulant activity[14]. Two triterpenoid saponins 
isolated from the aerial parts of A. precatorius exhibited 
anti-inflammatory activity[15]. The steroidal fraction of seeds 
of A. precatorius causes decrease in production and release 
of testosterone in testis of rats[16]. Abruquinone A, an 
isoflavanquinone isolated from A. precatorius significantly 
reduces the bradykinin- and substance P-induced plasma 
extravasations in normal as well as in compound 48/80-
pretreated mice[17]. Three new triterpenoids (20S, 22S)-3-毬, 22-
dihydroxycucurbita-5(10),24-diene-26,29-dioic acid 毮
-lactone, 3-O-[6’-methyl-毬-D-glucuronopyranosyl]-3
毬, 22毬-dihydroxyolean-12-en-29-oic acid methyl ester 
and 3-O-毬-D-glucuronopyranosylsophoradiol methyl 
ester isolated from methanol extract of leaves[18]. A new 
biologically active flavonol glycoside 7,3’,5’-trimethoxy-
4’-hydroxy flavone-3-O-毬-D-galactosyl-(l→4)-alpha-
L-xyloside isolated from chloroform soluble fraction of 
methanol extract of the seeds of A. precatorius[19]. The seed 
proteins are rich in most of the essential amino acids, and 
they are deficient only in cystine and threonine[20]. A four 
abrusoside A-D novel sweet-tasting triterpene glycosides 
isolated n-butanol soluble extract from the leaves of A. 
precatorius[21]. In present study effect of ethanol extract of 
A. precatorius leaves (EAPL) was studied on egg albumin 
induced mast cell degranulation in mice and passive 
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cutaneous anaphylaxis in rats.
2. Materials and methods 
2.1. Plant material
  Leaves of A. precatorius were collected in December 2008, 
from Baramati localities, (Maharashtra, India), and plant was 
authenticated by Prof. R. B. Deshmukh, Dept. of Botany, 
Shardabai Pawar Mahila Mahavidyalaya, Baramati, (plant 
specimen number PASR 114). 
2.2. Extraction
  Dried and coarsely powder of A. precatorius leaves (500 g) 
extracted successively with ethanol (95 %) in soxhlet 
extractor. Solvent was evaporated in rotary evaporator 
dryness under reduced pressure to produce ethanol extract 
of A. precatorius leaves (EAPL) 10.26 % ethanol extract.
2.3. Animals
  Swiss albino mice of either sex weighing 25-30 g and rats 
weighing 150-170 g were housed under standard laboratory 
conditions. The animals had free access to food and water. 
The animal ethical committee of the institute approved 
all the protocols of the study (Registration No.1214/ac/08/
CPCSEA).
2.4. Drugs and chemicals
  Egg albumin, aluminium hydroxide and evan blue were 
purchased from (Himedia, India), disodium chromoglycate 
and dexamethasone.
2.5. Preliminary phytochemical screening
  The EAPL was subjected to preliminary phytochemical 
analysis using described methods[22,23].
2.6. Acute toxicity studies
  In acute toxicity study of EAPL, mice of either sex were 
divided into seven groups (n=6) and fasted for 18 h with 
water ad libitum. EAPL administered at six different doses 
of 800, 900, 1000, 1100, 1200 and 1300 (mg/kg, i.p). Control 
group was given the vehicle only (Tween-80, 1%) solution. 
The animals were observed for 72 h, and the LD50 was 
calculated[24,25]. 
2.7. Passive cutaneous anaphylaxis test
  The homologous antiserum used was prepared according 
to method described by Gautam et al. [26]. Briefly, albino 
rats were sensitized by subcutaneous injection of 100 mg 
egg albumin and 12 mg aluminium hydroxide, as adjuvant, 
on day 1, 3 and 5. On day 10, animals were bled and 
antiserum was collected. The separated antiserum was stored 
at -20 曟. The rats were divided in to five groups (n=5). 
The rat homologous antiserum (100 毺L) was injected into 
the shaved back skin of rats. After 24 h, group-I control 
received 5 mL/kg Tween-80 1%, groups II-IV received 
EAPL (100-150 mg/kg i.p.) and group-V, received disodium 
chromoglycate (50 mg/kg i.p.). The entire groups were 
injected with 0.5 mL of mixed solution of 0.5% Evan Blue, 
and 1% egg albumin (1:1) through tail vein 30 minutes after 
treatment.  The area of blue dye leakage was determined 
and expressed as the longest and shortest diameter of blue 
spots in mm2[26].
2.8. Mast cell degranulations
  Mice were divided into five groups (n=6). A three days 
treatment schedule was followed. Group-I received vehicle 
Tween-80 1%, (5 mL/kg, i.p.). Group-II-IV were treated 
with EAPL (100-150 mg/kg i.p.), and group-V received 
standard drug disodium chromoglycate (50 mg/kg. i.p.). On 
day 4, each animal was injected with 10 mL/kg, 0.9% saline 
solution, into peritoneal cavity, by gentle massage, peritoneal 
fluid was collected after five minute and transferred in to 
test tube containing 7-10 mL RPMI 1640 buffer medium (pH 
7.2-7.4). This solution was then centrifuged at 400-500 rpm. 
Pellets of mast cells were washed with same buffer medium 
twice by centrifugation, discarding supernatant. The cell 
suspension from all the groups of rats were challenged with 
egg albumin (100 毺g/mL) and incubated at 37 曟 for 10 
minute the cell suspension was stained with 1% toludine 
blue and observed under microscope. Total 100 cells were 
counted from different visual areas. Percent protection 
against degranulations was calculated[27].  
2.9. Statistical analysis 
  The results were reported as mean 依 SEM and analyzed 
for statistical significance using one way ANOVA followed 
by student Newman-Keuls test P<0.05 was considered 
significant.
3. Results 
3.1. Preliminary phytochemical screening
  Preliminary phytochemical investigation of EAPL observed 
the presence of steroids, saponin, alkaloids, flavonoids, and 
glycosides.
3.2. Acute toxicity studies 
  The LD50 value of EAPL when given intraperitoneally and 
tested in albino mice was found to be more than 1 300 mg/kg 
body weight.
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3.3. Passive cutaneous anaphylaxis test
  EAPL (100-150 mg/kg i.p.) showed significantly (P<0.001) 
reduction in the area of dye leakage in dose dependently 
when compared with control group as shown in Figure 
1. EAPL at dose 150 mg/kg showed (16.60依1.08) reduction 
of area of dye leakage was comparable to standard drug 
disodium chromoglycate. 
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Figure 1. Effect of EAPL on passive cutaneous anaphylaxis in rats.
 Values are mean 依 SEM, P< 0.001when compare with control.
3.4. Mast cell degranulations
  The control group showed (74.000 依 1.932) degranulation 
of mast cell while groups treated with EAPL (100-150 mg/
kg, i.p.) and disodium chromoglycate significantly (P<0.001) 
protect degranulation of mast cells. EAPL at dose (150 mg/kg) 
showed (28.000依0.860) and disodium chromoglycate (22.500依 
1.118) protection against degranulation as shown in Figure 2.
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Figure 2. Effect of EAPL on egg albumin induced degranulation of 
mast cell in rats.
Values are mean 依 SEM, P< 0.001when compare with control.
4. Discussion
  Phytochemical screening of EAPL showed the presence 
of saponin, flavonoids, alkaloids and glycosides. Saponin 
are reported to possesses mast cell stabilizing, antiallergic 
and antihistaminic activities[28-30]. Glycosides isolated 
from various plants reported to have antiasthmatic activity 
through several mechanisms i.e spasmolytic activity by 
relaxation of tracheal smooth muscle[31], and antiallergic 
activity[32]. Several flavonoids have been shown to possess 
smooth muscle relaxant and bronchodilator activity[33]. 
The flavonoids including apigenin and luteolin were 
known to inhibit basophil histamine release and neutrophil 
betaglucuronidase release, and thereby possess in vivo 
antiallergic activity[34-36]. These flavonoids also inhibited 
the histamine release induced by 48/80[37]. The anaphylactic 
allergic reaction is a life-threatening induces release 
of mediators such as histamine and pro-inflammatory 
cytokines and can be elicited by various stimuli. EAPL at 
doses (100-150 mg/kg) significantly inhibit egg abumin 
induced leakage of dye from dorsal skin of rat when 
compare to control group. Control group showed (42.400 
依 1.806) mm2 area of dye leakage while EAPL at dose 150 
mg/kg reduces area of dye leakage (16.600依 1.080) mm2. 
Hence EAPL shows antihistaminic and anti-inflammatory 
mechanism by inhibiting egg albumin induced leakage 
of dye. The degranulation of mast cell occurs in response 
to the immunological stimuli in which antigen antibody 
reactions are predominant. EAPL at doses (100-150 mg/kg) 
significantly protect egg albumin induced degranulation of 
mast cell in a dose dependent manner. EAPL at 150 mg/kg 
protect mast cell comparable to disodium chromoglycate. 
Hence antiasthmatic activity of EAPL may be due to 
presence of flavonoids and saponin. In conclusion EAPL are 
effective in treatment of asthma as it shows antiallegic and 
mast cell stabilizing potential.
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